1. Home
  2. AMRX vs MLCO Comparison

AMRX vs MLCO Comparison

Compare AMRX & MLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • MLCO
  • Stock Information
  • Founded
  • AMRX 2002
  • MLCO 2004
  • Country
  • AMRX United States
  • MLCO Hong Kong
  • Employees
  • AMRX N/A
  • MLCO N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • MLCO Hotels/Resorts
  • Sector
  • AMRX Health Care
  • MLCO Consumer Discretionary
  • Exchange
  • AMRX Nasdaq
  • MLCO Nasdaq
  • Market Cap
  • AMRX 2.5B
  • MLCO 2.5B
  • IPO Year
  • AMRX N/A
  • MLCO 2006
  • Fundamental
  • Price
  • AMRX $8.37
  • MLCO $8.43
  • Analyst Decision
  • AMRX Strong Buy
  • MLCO Buy
  • Analyst Count
  • AMRX 4
  • MLCO 5
  • Target Price
  • AMRX $11.50
  • MLCO $7.56
  • AVG Volume (30 Days)
  • AMRX 1.9M
  • MLCO 3.7M
  • Earning Date
  • AMRX 08-08-2025
  • MLCO 08-12-2025
  • Dividend Yield
  • AMRX N/A
  • MLCO N/A
  • EPS Growth
  • AMRX N/A
  • MLCO N/A
  • EPS
  • AMRX N/A
  • MLCO 0.14
  • Revenue
  • AMRX $2,830,186,000.00
  • MLCO $4,758,114,000.00
  • Revenue This Year
  • AMRX $9.84
  • MLCO $7.26
  • Revenue Next Year
  • AMRX $7.33
  • MLCO $5.97
  • P/E Ratio
  • AMRX N/A
  • MLCO $56.57
  • Revenue Growth
  • AMRX 13.42
  • MLCO 14.07
  • 52 Week Low
  • AMRX $6.32
  • MLCO $4.55
  • 52 Week High
  • AMRX $9.48
  • MLCO $8.90
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 65.61
  • MLCO 83.80
  • Support Level
  • AMRX $8.05
  • MLCO $6.00
  • Resistance Level
  • AMRX $8.24
  • MLCO $7.29
  • Average True Range (ATR)
  • AMRX 0.23
  • MLCO 0.25
  • MACD
  • AMRX 0.04
  • MLCO 0.17
  • Stochastic Oscillator
  • AMRX 93.15
  • MLCO 96.43

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About MLCO Melco Resorts & Entertainment Limited

Melco Resorts and Entertainment Ltd is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 81% from Macao with the rest largely from the Philippines as of 2024.

Share on Social Networks: